The top 50 Signal strength of AEs at the PT level ranked by ROR for TXA in VigiAccess.
The top 50 Signal strength of AEs at the PT level ranked by ROR for TXA in VigiAccess.
Jing Feng (177843) +2 more
core +1 more source
Metaanálisis de eventos adversos y problemas de medicamentos relacionados a tocilizumab [PDF]
, 2021 PdfLa Artritis Reumatoide es una enfermedad sistémica autoinmune, cuya característica principal es la de provocar una considerable inflamación en la membrana sinovial que protege y lubrica las articulaciones causando dolor, hinchazón, rigidez y pérdida ...
Espinoza Vallejo, María Elena
core +1 more source
Frontiers in EndocrinologyBackgroundEndocrine therapy is central to the treatment of hormone receptor-positive breast cancer, yet hepatobiliary adverse-event reporting across endocrine agents remains incompletely characterized.
Weiguo Mao +3 more
doaj +1 more source
Reacción similar a la enfermedad del suero secundaria al uso de cefalotina: reporte de un caso
Infectio, 2022 Serum sickness (SS) and SS-like reactions (SSLR) are indistinguishable clinical entities but with different pathophysiological processes, particularly regarding its impact on the complement system.
Germán Sepúlveda-Barbosa
doaj +1 more source
Drugs Associated with Increased Urine Oxalate Using FAERS and the VigiAccess Database
Abstract Background: To identify drugs associated with increased urinary oxalate excretion using the FDA Adverse Event Reporting System (FAERs) and VigiAccess databases, providing insights into potential medication-related risk factors for hyperoxaluria.
Feiyu Sun +3 more
openaire +1 more source
, 2021 O presente trabalho teve por objetivo analisar as ocorrências da classificação “medicamento ineficaz” como efeito adverso dos seguintes medicamentos utilizados no tratamento da artrite reumatoide: Adalimumab, Etanercept, Infliximab e Golimumab ...
Ansante, Luciana Claudina +1 more
core +1 more source
Sintilimab Pharmacovigilance in Real-World Practice: Analysis Utilizing the WHO VigiAccess Database
Abstract Sintilimab, a high-affinity PD-1 inhibitor, blocks the interaction between PD-1 and PD-L1 to restore T-cell function. Clinically used with chemotherapy for cancers like non-small cell lung carcinoma and hepatocellular carcinoma, its adverse event (AE) profile remains critical. Here we conducted the pharmacovigilance analysis of
Youjia Guo +9 more
openaire +1 more source
Safety Profile and Signal Detection of Oxazolidinone Antibiotics Using WHO-VigiAccess Database
Bali Medical JournalObjective: Oxazolidinone antibiotics are mainly used for skin and soft tissue infections,sepsis,bone marrow inflammation and other diseases caused by Gram-positive bacteria. Despite the emergence of oxazolidinones as a preferred treatment for drug-resistant Gram-positive bacterial infections, there remains a scarcity of large-scale, real-world studies ...
Renzhu Liu +6 more
openaire +1 more source
Antiplatelet therapy and central nervous system hematomas: a cohort study using real-world data from the FAERS and VigiAccess databases. [PDF]
Int J SurgBackground: Antiplatelet therapy is a cornerstone in the management of atherosclerotic cardiovascular disease. However, the risk profile of central nervous system (CNS) hematomas associated with antiplatelet agents remains incompletely characterized ...
Wang L, Cai H, Zhao S.
europepmc +3 more sources
Safety of oral nifuroxazide – analysis of data from a spontaneous reporting system [PDF]
, 2019 Nifuroxazide is a popular chemotherapeutic agent, that is widely used in Poland in acute and chronic bacterial diarrhea treatment. It is available in pharmacies as over-the-counter tablets for adults and a suspension on prescription for children. The aim
Głowacka, Krystyna +4 more
core +1 more source